Tag: life sciences
-
FDA Clears A.I. Software Detecting Diabetic Eye Disease
The Food and Drug Administration authorized a system for detecting diabetic retinopathy, a condition threatening the vision of people with diabetes, that uses artificial intelligence to analyze images of patients’ retinas.
-
Implanted Sensor Monitors Alcohol in Body
A university bioengineering lab developed a tiny implantable sensor that in lab tests tracked alcohol levels in bodily fluids, while requiring little power, making it capable of operating for extended periods.
-
Gene Therapy Biotech Acquired in $8.7 Billion Deal
A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion.
-
Bio-Inspired Surgical Camera Highlights Cancer Tissue
A camera modeled on capabilities of a butterfly’s eye offers surgeons definitive images of tumor tissue for removal, as demonstrated in tests with lab animals and patients with breast cancer.
-
Stem Cell Eye Implants Safe, Stop Visual Function Loss
Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function.
-
Lilly, Cell Implants Start-Up Partner on Diabetes
Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases.
-
New Company Acquires Off-the-Shelf T-Cell Cancer Therapies
A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells.
-
Cough Suppressant Produced from Engineered Yeast Cells
A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast.
-
Nanotech Pain Drug Formulations Developed
A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs.
-
Antibodies Licensed for Multi-Target Immunotherapies
MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets.